Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine-Reference-Cited by-同舟云学术

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine

Published:2007-06 Issue:26 Volume:25 Page:4960-4966
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gruener Norbert H.,Gerlach Tilman J.,Ulsenheimer Axel,Diepolder Helmut M.,Wierenga Eddy,Zachoval Reinhart,Heeg Malte,Pape Gerd Rudolf,Jung Maria-Christina

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference18 articles.

1. Hepatitis B virus immunopathogenesis;Chisari;Annu Rev Immunol,1995

2. T cell recognition of hepatitis B and C viral antigens;Jung;Eur J Clin Invest,1994

3. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection;Livingston;J Immunol,1997

4. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans;Livingston;J Immunol,1999

5. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen;Ferrari;J Clin Invest,1991

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B;Human Vaccines & Immunotherapeutics;2019-12-12

2. Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy;Journal of Hepatology;2013-02